Abstract

Chronic mesh infection is one of the most challenging clinical conditions in the abdominal wall surgery. Whether an infected mesh must be totally removed or not, the role of antibiotics, the right timing for a repair and guidelines on how to treat the abdominal wall must be discussed. Incidences of mesh-related infection after herniare pair of up to 8% have been reported. The rate of infection is influenced considerably by underlying co-morbidity, and seems to be increased in patients with diabetes, immunosuppression or obesity. A clinician should strongly consider the possibility of a mesh-related infection in any patient who presents with fever of unknown aetiology, symptoms and ⁄ or signs of inflammation of the abdominal wall in the area of the mesh, or other less common clinical manifestations of mesh infection, such as an enterocutaneous fistula or abdominal abscess in the area of the mesh. Imaging techniques, including ultrasound and ⁄ or computerised tomography, can be useful for the diagnosis of mesh infection. When a mesh-related infection occurs, a combined medical and surgical approach involving intravenous antimicrobial agents and complete surgical removal of the mesh is the preferred management strategy.

Keywords: Hernia repair, infectious complications, mesh-related infection, abdominal wall sinus.

1.      Seker D, Kulacoglu H (2011) Long-term complications of mesh repair for abdominal wall hernias. J Long Term Eff Med Implants 21:205–218

2.      Deysine M, Soroff HS (1990) Must we specialize herniorrhaphy for better results? Am J Surg 160:239–240

3.      Heniford BT, Park A, Ramshaw BJ, Voeller G. Laparoscopic repair of ventral hernias: nine years’ experience with 850 consecutive hernias. Ann Surg 2003; 238: 391–399.

4.      Leber GE, Garb JL, Alexander AI, Reed WP. Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 1998; 133: 378–382.

5.      McGreevy JM, Goodney PP, Birkmeyer CM, Finlayson SR, Laycock WS, Birkm-eyer JD. A prospective study comparing the complication rates between laparoscopic and open ventral hernia repairs. SurgEndosc 2003; 17: 1778–1780.

6.      Amid PK. Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia 1997; 1: 15–21.

7.      Deysine M. Pathophysiology, prevention, and management of prosthetic infections in hernia surgery. SurgClin North Am 1998; 78: 1105–1115.

8.      Troy MG, Dong QS, Dobrin PB, Hecht D. Do topical antibiotics provide improved prophylaxis against bacterial growth in the presence of polypropylene mesh? Am J Surg 1996; 171: 391–393.

9.      Lazorthes F, Chiotasso P, Massip P, Materre JP, Sarkissian M. Local antibiotic prophylaxis in inguinal hernia repair. SurgGynecolObstet 1992; 175: 569–570.

10.  Musella M, Guido A, Musella S. Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernias. Eur J Surg 2001; 167: 130–132.

11.  Celdran A, Frieyro O, De La Pinta JC et al. The role of antibiotic prophylaxis on wound infection after mesh hernia repair under local anesthesia on an ambulatory basis. Hernia 2004; 8: 20–22.

12.  Petersen S, Henke G, Freitag M, Faulhaber A, Ludwig K. Deep prosthesis infection in incisional hernia repair: predictive factors and clinical outcome. Eur J Surg 2001; 167: 453–457.